Stay updated with breaking news from Nasdaq Dbtx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Decibel Therapeutics, Inc. (NASDAQ:DBTX – Get Rating) was the target of a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 1,060,000 shares, an increase of 21.3% from the April 15th total of 874,000 shares. Based on an average daily volume of 66,500 shares, the […]
Decibel Therapeutics, Inc. (NASDAQ:DBTX – Get Rating) has been assigned a consensus recommendation of “Buy” from the nine ratings firms that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average twelve-month target price […]
- Podium presentation at Association for Research in Otolaryngology Annual MidWinter Meeting highlighting DB-OTO dose-ranging studies with expression...